Related Experiment Video
Updated: Jun 13, 2025
08:09
Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
Published on: July 25, 2017
12.3K
The Feasibility for Screening for Ovarian Cancer
Miyo K Chatanaka1, Eleftherios P Diamandis2
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
EJIFCC
|September 9, 2024
Summary
A new molecular test, Early oVArian cancer (EVA), shows limited predictive value for early high-grade serous ovarian cancer detection. Both EVA and CA125 are unlikely to be effective for population-wide screening in at-risk women.
Area of Science:
- Oncology
- Molecular Diagnostics
- Biomarker Discovery
Background:
- High-grade serous ovarian cancer (HGSOC) is often diagnosed at late stages, limiting treatment efficacy.
- Early detection of HGSOC is crucial for improving patient outcomes and survival rates.
